GENENTECH, INC for GENENTECH INC

Immigration IMM

-Issues relating to limits and restrictions on the immigration of high skilled workers -Issues relating to the immigration of medical researchers

Contacted: Labor, Dept of (DOL); Homeland Security, Dept of (DHS)

Budget/Appropriations BUD

Bills -H.R. 2617 Consolidated Appropriations Act, FY2023 Issues -Issues related to FDA and HHS program funding for the FY23 Labor, HHS, Education and Related Agencies, and FY22 Agriculture, Rural Developments, Food, and Drug Administrations, and Related Agencies Appropriation bills -Strategic National Stockpile (SNS) Funding and Oversight -Funding for FDA e-labeling rule implementation -Patient access to Part B medicines during the COVID-19 public health emergency -Issues related to 340B program oversight -Support for increased investments to address antimicrobial resistance -Deficit reduction, reconciliation

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2617 (117th)

Copyright/Patent/Trademark CPT

Bills -S. 4417 Patent Trial and Appeal Board Reform Act -S. 4734 Patent Eligibility Restoration Act -S. 1435 - Affordable Prescriptions for Patients Act of 2021 -H.R. 2873 Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 -H.R. 2884 Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act Issues -Intellectual property and process patent issues -Patent litigation reforms -PTAB and IPR processes -Section 101 Reform -Domestic and international compulsory licensing issues -March-in Rights

Contacted: U.S. Trade Representative (USTR); Patent & Trademark Office (PTO)

Bills named: S. 1435 (117th), H.R. 2873 (117th), S. 4417 (117th), H.R. 2884 (117th), S. 4734 (117th)

Health Issues HCR

Bills -H.R. 2163/S. 464 - Safe Step Act -S.1773 - Prescription Drug Pricing Dashboard Act -H.R. 5376 - Build Back Better Act -H.R. 3684- Infrastructure Investment and Jobs Act -H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act -S.2076/H.R. 3932 PASTEUR Act -S. 3799- PREVENT Pandemics Act -H.R.4521 - COMPETES Act of 2022 -S.1260 - United States Innovation and Competition Act of 2021 -H.R.6963 - Accelerated Approval Integrity Act of 2022 -H.R.6996 - Accelerating Access for Patients Act of 2022 -H.R. 2565 / S.2952 the FDA Modernization Act -H.R. 6972 - Give Kids a Chance Act -H.R. 1730 - STAT Act -H.R. 7032 - Increasing Transparency in Generic Drug Applications Act -H.R. 5030/S. 2706 - DIVERSE Trials Act -H.R. 6584 - DEPICT Act -H.R. 9476- Influenza Act of 2022 Issues -Issues related to the 340B Drug Discount Program -Issues relating to drug pricing -Development of policies to advance antimicrobial research, antiviral research, and novel product development environment, including advancing new market incentives -Issues and policies relating to the Food and Drug Administration including biopharmaceutical development, drug safety and counterfeiting, and biosimilars -General education about policies impacting pharmaceutical development, approval, reimbursement and pricing -Issues related to healthcare legislation -Patient access to Part B medicines during the COVID-19 public health emergency -Issues related to health equity, diversity, and inclusion in clinical trials -Issues related to advanced development and procurement of medical countermeasures (MCMs) -Issues related to patient assistance and access -Issues relating to privacy and securing the data of and personal information of consumers -Issues relating to medical research data -Issues relating to screening and diagnostics -Issues related to public health preparedness and response -Issues related to awareness about diabetic eye diseases in minority populations

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1730 (117th), H.R. 7032 (117th), H.R. 4521 (117th), H.R. 6996 (117th), S. 1773 (117th), H.R. 5376 (117th), H.R. 3684 (117th), H.R. 3932 (117th), S. 2076 (117th), H.R. 6972 (117th), S. 464 (117th), S. 2706 (117th), H.R. 2565 (117th), S. 1260 (117th), H.R. 9476 (117th), H.R. 5030 (117th), H.R. 6963 (117th), H.R. 6584 (117th), S. 2952 (117th), H.R. 2163 (117th), H.R. 5801 (117th), S. 3799 (117th)

Medicare/Medicaid MMM

H.R.5260 - Reduced Costs and Continued Cures Act H.R. 5125 - the Strengthening Innovation in Medicare and Medicaid Act H.R. 5376 - Build Back Better Act -Issues related to Medicare and Medicaid coverage and reimbursement -Issues related to the 340B Drug Discount Program -Issues related to drug pricing -Medicare reimbursement for biosimilars -Issues related to CMMI

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5125 (117th), H.R. 5376 (117th), H.R. 5260 (117th)

Taxation/Internal Revenue Code TAX

H.R. 1304, the American Innovation and R&D Competitiveness Act and S. 749 American Innovation and Jobs Act S.1260 - United States Innovation and Competition Act of 2021 -Issues related to R&D tax deductions and expense amortization -Issues related to international taxation, including foreign-derived intangible income and interest deductions -Issues related to supply chain incentives

Contacted: SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES

Bills named: S. 1260 (117th), H.R. 1304 (117th), S. 749 (117th)

Manufacturing MAN

S.3401 - Safe Drug Act H.R. 7121, Protecting our Pharmaceutical Supply Chain from China Act of 2022 S.3509 - Creating Efficiency in Foreign Facility Inspections Act -Issues related to pharmaceutical supply chains -Issues related to reporting on location of origin of pharmaceutical products -Issues related to drug shortages -Issues related to pharmaceutical manufacturing

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3401 (117th), S. 3509 (117th), H.R. 7121 (117th)

Trade (domestic/foreign) TRD

H.R. 3788, the Protecting American Innovation Act H.R. 3811, the Trade Related Intellectual Property Protection Act H.R. 7185, the Federal Contracting for Peace and Security Act -Issues relating to trade policy and negotiations impacting the biopharmaceutical industry including the TRIPS IP Waiver -Issues related to compulsory licensing of foriegn patents -Issues related to WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)

Contacted: SENATE; U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3788 (117th), H.R. 7185 (117th), H.R. 3811 (117th)

Medical/Disease Research/Clinical Labs MED

H.R. 2471 Consolidated Appropriations Act, FY2022 S.2076/H.R. 3932 PASTEUR Act H.R.7667 - Food and Drug Amendments of 2022 S.4348 - FDASLA Act of 2022 H.R.6963 - Accelerated Approval Integrity Act of 2022 H.R.6996 - Accelerating Access for Patients Act of 2022 H.R. 2565 / S.2952 the FDA Modernization Act H.R. 6972 - Give Kids a Chance Act H.R. 1730 - STAT Act H.R. 7032 - Increasing Transparency in Generic Drug Applications Act H.R. 5030/S. 2706 - DIVERSE Trials Act H.R. 6584 - DEPICT Act H.R.3085 - ENACT Act of 2021 -Issues related to public health protection including influenza development and preparedness -Issues related to antimicrobial and antiviral research and product development -Issues related to novel coronavirus and COVID-19 research and product development -Issues related to drug development including PDUFA and Cures 2.0

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7667 (117th), H.R. 3932 (117th), S. 2076 (117th), H.R. 7032 (117th), H.R. 3085 (117th), S. 2952 (117th), H.R. 5030 (117th), S. 4348 (117th), H.R. 6996 (117th), H.R. 2565 (117th), H.R. 2471 (117th), H.R. 6963 (117th), S. 2706 (117th), H.R. 6584 (117th), H.R. 1730 (117th), H.R. 6972 (117th)

Pharmacy PHA

H.R. 2163/S. 464 - Safe Step Act H.R. 5376 - Build Back Better Act H.R. 5801 - Help Ensure Lower Patient (HELP) Copays Act -Drug pricing issues -Prescription Drug User Fee Act reauthorization -Issues related to prescription drug value -Issues related to the 340B Drug Discount Program

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5801 (117th), H.R. 2163 (117th), H.R. 5376 (117th), S. 464 (117th)